GREG ROSE, President
CTG, Rose was General Manager of the Global Renal Therapy Business
of Baxter International Inc. in Japan. Previously at Baxter
he was Director of New Business Development for Baxter Limited
(Japan), Manager of Business Planning for the Americas and Pacific
Division (AMPAC), and Organization Planning Analyst in Baxter's
Corporate Human Resources Department.
is presently Representative Director of ev3, K.K., and was
previously Representative Director of ResMed, K.K., Aksys
Japan, K.K., TherOx, K.K., Total Renal Care Japan, K.K.,
MediSense Japan, K.K., and Nova Viomedical, K.K., all of
which he helped to establish and initially to manage.
received his B.A., summa cum laude, from Wabash College where
he was an Eli Lilly Scholar and member of Phi Beta Kappa. He
received his M.A. in Economics from Vanderbilt University where
he was a Harold Stirling Vanderbilt Fellow.
is an active member of Tokyo Baptist Church where he previously
served as Vice Chairman of the Finance and Properties Committee.